Official Title
The Efficacy of Ivermectin in COVID-19 Treatment
Brief Summary

Efficacy of Ivermectin in COVID-19 treatment

Detailed Description

Clinical Study Evaluating the Efficacy of Ivermectin in COVID-19 treatment

Status
Completed
Conditions
COVID
Interventions

Drug: Ivermectin

Ivermectin treatment
Other Name: iverzine, ivermectin

Eligibility Criteria

Inclusion Criteria:

- All Adult Patients aging from 20 to 65 years-old with COVID-19 confirmed by pharyngeal
swab PCR.

Exclusion Criteria:

- Allergy or contraindication to the drugs used in the study.

- Pregnant and lactating mothers.

- Patients with cardiac problems.

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
Egypt
Locations

Sherief Abd-Elsalam
Tanta, Egypt

Investigators

sherief Abd-Elsalam, Ass. Prof., Principal Investigator
ass. Prof. Tropical Medicine

Sponsors / Collaborators
Tanta University
NCT Number
NCT04403555
MeSH Terms
Ivermectin